Quantinno Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.05M Buy
155,337
+80
+0.1% +$1.53K ﹤0.01% 1838
2026
Q2
$2.27M Buy
155,257
+29,431
+23% +$436K ﹤0.01% 1870
2026
Q1
$1.82M Buy
125,826
+24,277
+24% +$282K ﹤0.01% 1684
2025
Q4
$976K Buy
101,549
+42,955
+73% +$411K ﹤0.01% 1814
2025
Q3
$551K Buy
58,594
+45,186
+337% +$432K ﹤0.01% 1930
2025
Q2
$142K Buy
+13,408
New +$169K ﹤0.01% 2451

Other funds holding ANIK

Quantinno Capital Management's ANIK Position: Q3 2026 in Review

Quantinno Capital Management increased its Anika Therapeutics (ANIK) stake by 0.05% in Q3 2026, buying an estimated $1.53K and bringing the position to 155,337 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Quantinno Capital Management first reported a position in ANIK in Q2 2025 and has held it in 6 quarters since. 140 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • Quantinno Capital Management held 155,337 shares of Anika Therapeutics worth $3.05M as of Q3 2026.
  • Quantinno Capital Management bought 80 Anika Therapeutics shares in Q3 2026, an estimated $1.53K.
  • Anika Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1838 holding.
  • Quantinno Capital Management first reported a position in Anika Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • 140 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.